WHO's review of drug regulatory processes “useful”, say participants Comment 10 February 2013 Pages: 4 - 4
Caesarean sections give birth to little cost differences vs vaginal delivery Clinical study 10 February 2013 Pages: 5 - 5
Rofecoxib introduction in Italy affects prescribing, costs in OA Clinical study 10 February 2013 Pages: 5 - 5
Β-Blocker use significantly improved with nurse facilitation Clinical study 10 February 2013 Pages: 7 - 7
Oprelvekin “not worth the cost” for thrombocytopenia prophylaxis Clinical study 10 February 2013 Pages: 7 - 7
Paediatrician compliance with otitis media guidelines low Clinical study 10 February 2013 Pages: 7 - 7
Costs of end-stage renal disease “extremely high” in the US Clinical study 10 February 2013 Pages: 8 - 8
Specialist influence on general practitioner prescribing Clinical study 10 February 2013 Pages: 8 - 8
Hypertension control poor despite medication use in China Clinical study 10 February 2013 Pages: 9 - 9
Lower costs with sequential high-dose chemotherapy in breast cancer Clinical study 10 February 2013 Pages: 9 - 9
Rotavirus vaccine needs to be safer, recommended, say US paediatricians Clinical study 10 February 2013 Pages: 9 - 9
Docetaxel/cisplatin confers QOL, survival benefits in NSCLC Media release 10 February 2013 Pages: 10 - 10
Donepezil improves activities of daily living in Alzheimer's disease Clinical study 10 February 2013 Pages: 10 - 10
Antiretrovirals access to increase with AHF, Gilead partnership News item 10 February 2013 Pages: 11 - 11
Immunisation fund tops $US1b, WHO calls for free anti-TB drugs News item 10 February 2013 Pages: 11 - 11
US Medicare bill should include cost-effectiveness research News item 10 February 2013 Pages: 11 - 11
Initiative to tackle counterfeit drugs announced by US FDA Media release 10 February 2013 Pages: 12 - 12